Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0DOTIX
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
CUSP06
|
|||||
| Synonyms |
AMT 707; CUSP 06; AMT-707; AMT707; CUSP-06; CUSP06
Click to Show/Hide
|
|||||
| Organization |
Multitude Therapeutics, Inc.; OnCusp Therapeutics
|
|||||
| Drug Status |
Clinical candidate
|
|||||
| Indication |
In total 1 Indication(s)
Solid tumors [ICD11:2A00-2A0Z|2B50-2F9Z]
Clinical candidate
|
|||||
| Drug-to-Antibody Ratio |
8
|
|||||
| Antibody Name |
Undisclosed
|
|||||
| Antigen Name |
Cadherin-6 (CDH6)
|
Antigen Info | ||||
| Payload Name |
Exatecan
|
Payload Info | ||||
| Therapeutic Target |
DNA topoisomerase 1 (TOP1)
|
Target Info | ||||
| Linker Name |
Protease cleavable linker
|
Linker Info | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.